Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
BMC Nephrol ; 20(1): 207, 2019 06 06.
Artigo em Inglês | MEDLINE | ID: mdl-31170935

RESUMO

BACKGROUND: Pregabalin is a medication used to treat epilepsy, neuropathic pain and generalised anxiety disorder. The most common side effects of pregabalin include dizziness, drowsiness, weight gain, ataxia and diplopia. On the other hand, neutropenia and rash are rare side effects of pregabalin, and at the time of writing, there are only two documented cases of neutropenia and one of rash in the literature, none of which involved renal transplant recipients. CASE PRESENTATION: We present a 37-year-old renal transplant recipient who was admitted with lethargy, sore throat, urticarial rash and neutropenia after recently being commenced on pregabalin. On physical examination, he had erythematous urticarial rash near his renal transplant scar, on his right elbow, left knee and left wrist. Bacterial/viral serology and immunology were all negative. A blood film confirmed neutropenia and revealed reactive lymphocytes and neutrophil left shift, and those features were compatible with drug reaction. After cessation of the pregabalin, the neutropenia resolved. No other causes of neutropenia or urticarial rash were identified. CONCLUSION: To the best of our knowledge, we have described the first case of concomitant pregabalin-induced neutropenia and urticarial rash in a kidney transplant patient. This case report highlights the importance of close monitoring when starting any new medications, particularly in the immunosuppressed population, and is relevant because of the growing usage of pregabalin for treating neuropathic pain in such patients and the risk that a missed pregabalin-related neutropenia could lead to unnecessary modifications of the immunosuppressive treatment.


Assuntos
Falência Renal Crônica/cirurgia , Transplante de Rim , Neuralgia/tratamento farmacológico , Pregabalina , Adulto , Analgésicos/administração & dosagem , Analgésicos/efeitos adversos , Exantema/induzido quimicamente , Exantema/diagnóstico , Exantema/terapia , Humanos , Hospedeiro Imunocomprometido , Falência Renal Crônica/etiologia , Transplante de Rim/efeitos adversos , Transplante de Rim/métodos , Masculino , Neutropenia/induzido quimicamente , Neutropenia/diagnóstico , Neutropenia/terapia , Pregabalina/administração & dosagem , Pregabalina/efeitos adversos , Transplantados , Resultado do Tratamento , Suspensão de Tratamento
2.
Clin Nephrol ; 83(2): 121-3, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24361058

RESUMO

Enzymatic creatinine assays are considered superior to Jaffe assays due to greater analytical specificity. We report a case of phenindione interference with an enzymatic assay resulting in significant misclassification in a patient with chronic kidney disease (CKD). Analysis of creatinine values of a further 36 patients who were treated with phenindione showed significant negative interference of phenindione with the Roche enzymatic creatinine assay.


Assuntos
Creatinina/sangue , Ensaios Enzimáticos/métodos , Fenindiona/efeitos adversos , Insuficiência Renal Crônica/diagnóstico , Anticoagulantes/administração & dosagem , Anticoagulantes/efeitos adversos , Anticoagulantes/sangue , Erros de Diagnóstico , Taxa de Filtração Glomerular , Humanos , Masculino , Pessoa de Meia-Idade , Fenindiona/administração & dosagem , Fenindiona/sangue , Insuficiência Renal Crônica/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA